RESULTS	The 2-year patient/graft survival was 86.0 % / 73.7 % and 94.2 % / 90.3 % in CsA and FK506 groups , respectively ( P < 0.05 ) , with incidence of acute rejection of 10.5 % and 9.6 % ( P > 0.05 ) , and rate of abnormal liver function of 26.3 % and 15.4 % ( P < 0.05 ) , respectively .\